Showing results (301-310 of 351) with videos related to

Sort By:
Pageof 36
Plos One|March 9, 2013
Prevalent and incident bacterial vaginosis are associated with sexual and contraceptive behaviours in young Australian womenCatriona S Bradshaw, Jennifer Walker, Christopher K Fairley, et al.
The International Journal on Drug Policy|March 29, 2022
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020Anna Lee Wilkinson, Daniela K van Santen, Michael W Traeger, et al.
BMC Medicine|August 5, 2017
The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational studySwe Swe Thit, Ne Myo Aung, Zaw Win Htet, et al.
The Journal of Infectious Diseases|August 10, 2006
Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenzMark A Boyd, Andrew Carr, Kiat Ruxrungtham, et al.
The Lancet. Infectious Diseases|October 11, 2018
Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trialRebecca J Guy, James Ward, Louise M Causer, et al.
Open Forum Infectious Diseases|April 1, 2024
Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020Brendan L Harney, Rachel Sacks-Davis, Paul Agius, et al.
Current Opinion in HIV and AIDS|February 20, 2016
Which HIV patients should be screened for osteoporosis: an international perspectiveElena Alvarez, Waldo H Belloso, Mark A Boyd, et al.
The Journal of Infectious Diseases|September 21, 2011
Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trialHelen Byakwaga, Mark Kelly, Damian F J Purcell, et al.
Ebiomedicine|August 20, 2015
Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic AnalysisNathan W Cummins, Jacqueline Neuhaus, Haitao Chu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2017
Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysisAlexander J Stockdale, Matthew J Saunders, Mark A Boyd, et al.
Pageof 36